Disclaimer | LogIn     
1546-2080 Online :: 1546-203X Print
Angstrom Medica: Securing FDA Approval and Commercializing a Nanomedical Device
Volume 2, Issue 2

Andrew S. Baluch, Nanotechnology Law & Business

Nanotechnology could have a substantial impact on different medical products ranging from drug delivery to molecular diagnostics to bone replacement materials. However, few companies have successfully obtained Food and Drug Administration (FDA) approval to commercialize nanoscale materials and devices. In this article, Andrew Baluch explains how Angstrom Medica has become the first company to obtain FDA approval for a nanotechnology medical device and how it plans to capitalize on this achievement. The companys history and business strategy can be used as a model for other companies seeking to market nanotechnology in the medical arena.

Full Text (PDF)
Home   :   Aims & Scope    :   Editorial Board    :   Subscriptions   :   Partnerships  :   Contact Us
Nanotechnology Law & Business Copyright 2005